Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Pfizer's Must-Win FDA Vote
Motley Fool
Tue, 05/8/12 - 07:18 pm
FDA
Pfizer
rheumatoid arthritis
tofacitinib
Amgen
JNJ
Merck
Abbott Laboratories
Bright Future Ahead Of Abbott Despite Mounting Competition
Seeking Alpha
Tue, 05/8/12 - 07:17 pm
Abbott Laboratories
Merck
Nestle
Pfizer
Roche
Sanofi
Merck: Will Singulair Expiration Sink Its Stock?
Seeking Alpha
Tue, 05/8/12 - 10:55 am
Merck
Singulair
Novo Nordisk
Eli Lilly
JNJ
AstraZeneca
GSK
6 Best Biotech Stocks With More Upside Potential
Seeking Alpha
Mon, 05/7/12 - 12:17 pm
Amylin
Affymax
Human Genome Sciences
Merck
Regeneron
Threshold Pharmaceuticals
Vivus
Takeda
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Roche
Merck
dalcetrapib
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Eli Lilly
Pfizer
Sanofi
Illumina
These 5 Big Healthcare Stocks Have Major Upside In 2013
Seeking Alpha
Sat, 05/5/12 - 12:58 pm
Pfizer
Eli Lilly
Merck
Abbott Laboratories
PDL Biopharma
Merck's Weak Pipeline Will Sink Stock By 2013
Seeking Alpha
Sat, 05/5/12 - 12:38 pm
Merck
pipelines
Studies Shine Light on How Vioxx Raises Heart Risks
WSJ Online
Thu, 05/3/12 - 10:12 am
Vioxx
Merck
26 Drugs Facing FDA Approval in 2012
TheStreet.com
Wed, 05/2/12 - 11:12 am
drug approvals
FDA
Regeneron
ONYX Pharmaceuticals
Pfizer
Celgene
Arena Pharmaceuticals
Alexa
Gilead
Merck
Ironwood
Vivus
Navidea Biopharmaceuticals
NPS Pharmaceuticals
Raptor Pharmaceuticals
Santarus
Biogen Idec
2 Low-Growth Pharma Behemoths: Merck, J&J
Seeking Alpha
Tue, 05/1/12 - 12:36 pm
Merck
JNJ
Mylan
Cubist Pharmaceuticals
Understanding The Prospects Of Endocyte
Seeking Alpha
Tue, 05/1/12 - 07:14 am
Endocyte
Merck
Double-Digit Upside For Merck, Mylan Tops BioPharma
Seeking Alpha
Mon, 04/30/12 - 10:00 pm
Mylan
Merck
Bristol-Myers Squibb
On The Heels Of Chemo-Approved Cancer Drugs
Seeking Alpha
Mon, 04/30/12 - 10:13 am
Eli Lilly
Merck
Northwest Biotherapeutics
Roche
brain cancer
Temodar
Erbitux
DCVax
Avastin
Merck Wins Two Patent Lawsuits
NY Times, NY
Mon, 04/30/12 - 10:09 am
Merck
patents
Mylan
generics
Vytorin
Zetia
Merck's Q1 Results Mixed; All Eyes On Drug Pipeline
Yahoo/Investors
Sat, 04/28/12 - 12:34 pm
Merck
earnings
Merck Wins U.S. ZETIA® (ezetimibe)/ VYTORIN® (ezetimibe/simvastatin) Patent Infringement Lawsuit
Yahoo/BusinessWire
Sat, 04/28/12 - 12:29 pm
Merck
Zetia
lawsuits
patents
Mylan
generics
Merck Profit Tops Analyst Estimates on Diabetes Drugs
Bloomberg
Fri, 04/27/12 - 10:15 am
earnings
Merck
Earnings Preview: Merck to report on 1Q results
Yahoo/AP
Thu, 04/26/12 - 10:54 am
earnings
Merck
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Wed, 04/25/12 - 03:38 pm
Incivek
Vertex
hepatitis C
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Pfizer Will Surge Above $22 High On Strong Drug Portfolio
Seeking Alpha
Wed, 04/25/12 - 10:21 am
Pfizer
Abbott Laboratories
GSK
Merck
Nestle
Pages
« first
‹ previous
…
144
145
146
147
148
149
150
151
152
…
next ›
last »